BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22418021)

  • 21. In vivo cell tracking via ¹⁸F-fluorodeoxyglucose labeling: a review of the preclinical and clinical applications in cell-based diagnosis and therapy.
    Wu C; Ma G; Li J; Zheng K; Dang Y; Shi X; Sun Y; Li F; Zhu Z
    Clin Imaging; 2013; 37(1):28-36. PubMed ID: 23206605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A kit formulation for the preparation of [
    Man F; Khan AA; Carrascal-Miniño A; Blower PJ; T M de Rosales R
    Nucl Med Biol; 2020; 90-91():31-40. PubMed ID: 32979725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging cellular pharmacokinetics of 18F-FDG and 6-NBDG uptake by inflammatory and stem cells.
    Zaman RT; Tuerkcan S; Mahmoudi M; Saito T; Yang PC; Chin FT; McConnell MV; Xing L
    PLoS One; 2018; 13(2):e0192662. PubMed ID: 29462173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a novel imaging system for cell therapy in the brain.
    Micci MA; Boone DR; Parsley MA; Wei J; Patrikeev I; Motamedi M; Hellmich HL
    Stem Cell Res Ther; 2015 Jul; 6(1):131. PubMed ID: 26194790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging the in vivo fate of human T cells following transplantation in immunoincompetent mice - implications for clinical cell therapy trials.
    Berglund D; Karlsson M; Palanisamy S; Carlsson B; Korsgren O; Eriksson O
    Transpl Immunol; 2013 Dec; 29(1-4):105-8. PubMed ID: 24080297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tracking Neural Stem Cells in vivo: Achievements and Limitations.
    Xue CR; Wang K; Zhang MZ; Wang Z; Song YY; Yu HJ; Hao Y; Guan YT
    Stem Cell Rev Rep; 2022 Jun; 18(5):1774-1788. PubMed ID: 35122628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ⁵²Mn production for PET/MRI tracking of human stem cells expressing divalent metal transporter 1 (DMT1).
    Lewis CM; Graves SA; Hernandez R; Valdovinos HF; Barnhart TE; Cai W; Meyerand ME; Nickles RJ; Suzuki M
    Theranostics; 2015; 5(3):227-39. PubMed ID: 25553111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo neural stem cell imaging: current modalities and future directions.
    Gera A; Steinberg GK; Guzman R
    Regen Med; 2010 Jan; 5(1):73-86. PubMed ID: 20017696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 99mTc-based imaging of transplanted neural stem cells and progenitor cells.
    Gleave JA; Valliant JF; Doering LC
    J Nucl Med Technol; 2011 Jun; 39(2):114-20. PubMed ID: 21565954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography based in-vivo imaging of early phase stem cell retention after intramyocardial delivery in the mouse model.
    Lang C; Lehner S; Todica A; Boening G; Franz WM; Bartenstein P; Hacker M; David R
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1730-8. PubMed ID: 23860738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lost signature: progress and failures in in vivo tracking of implanted stem cells.
    von der Haar K; Lavrentieva A; Stahl F; Scheper T; Blume C
    Appl Microbiol Biotechnol; 2015 Dec; 99(23):9907-22. PubMed ID: 26373727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of adoptively transferred porcine T-lymphoblasts tracked by (18)F-2-fluoro-2-deoxy-D-glucose and position emission tomography.
    Eriksson O; Sadeghi A; Carlsson B; Eich T; Lundgren T; Nilsson B; Tötterman T; Korsgren O; Sundin A
    Nucl Med Biol; 2011 Aug; 38(6):827-33. PubMed ID: 21843778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell tracking in human trials: a meta-regression.
    McColgan P; Sharma P; Bentley P
    Stem Cell Rev Rep; 2011 Nov; 7(4):1031-40. PubMed ID: 21475954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tracking stem cell therapy in the myocardium: applications of positron emission tomography.
    Zhang Y; Ruel M; Beanlands RS; deKemp RA; Suuronen EJ; DaSilva JN
    Curr Pharm Des; 2008; 14(36):3835-53. PubMed ID: 19128236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo.
    Gildehaus FJ; Haasters F; Drosse I; Wagner E; Zach C; Mutschler W; Cumming P; Bartenstein P; Schieker M
    Mol Imaging Biol; 2011 Dec; 13(6):1204-14. PubMed ID: 21080231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular imaging in stem cell-based therapies of cardiac diseases.
    Li X; Hacker M
    Adv Drug Deliv Rev; 2017 Oct; 120():71-88. PubMed ID: 28734900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives on assessment of stem cell therapy in stroke by 18F-FDG PET.
    Cross DJ; Minoshima S
    J Nucl Med; 2013 May; 54(5):668-9. PubMed ID: 23512356
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dynamic analysis of pharmacokinetics of orally administered drugs using positron emission tomography].
    Kataoka M
    Yakugaku Zasshi; 2012; 132(8):911-7. PubMed ID: 22864349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct Cell Radiolabeling for
    Gawne PJ; Man F; Blower PJ; T M de Rosales R
    Chem Rev; 2022 Jun; 122(11):10266-10318. PubMed ID: 35549242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing cell trafficking by noninvasive imaging techniques: applications in experimental tumor immunology.
    Ottobrini L; Lucignani G; Clerici M; Rescigno M
    Q J Nucl Med Mol Imaging; 2005 Dec; 49(4):361-6. PubMed ID: 16407819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.